vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and PLAYSTUDIOS, Inc. (MYPS). Click either name above to swap in a different company.
PLAYSTUDIOS, Inc. is the larger business by last-quarter revenue ($55.4M vs $31.1M, roughly 1.8× LIFECORE BIOMEDICAL, INC. \DE\). PLAYSTUDIOS, Inc. runs the higher net margin — -24.7% vs -32.1%, a 7.4% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -18.3%). PLAYSTUDIOS, Inc. produced more free cash flow last quarter ($3.6M vs $25.0K). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -15.6%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.
LFCR vs MYPS — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $55.4M |
| Net Profit | $-10.0M | $-13.7M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | -17.7% |
| Net Margin | -32.1% | -24.7% |
| Revenue YoY | -4.5% | -18.3% |
| Net Profit YoY | -52.0% | 38.9% |
| EPS (diluted) | $-0.29 | $-0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $55.4M | ||
| Q3 25 | $31.1M | $57.6M | ||
| Q2 25 | — | $59.3M | ||
| Q1 25 | $35.2M | $62.7M | ||
| Q4 24 | $32.6M | $67.8M | ||
| Q3 24 | $24.7M | $71.2M | ||
| Q2 24 | — | $72.6M | ||
| Q1 24 | $35.7M | $77.8M |
| Q4 25 | — | $-13.7M | ||
| Q3 25 | $-10.0M | $-9.1M | ||
| Q2 25 | — | $-2.9M | ||
| Q1 25 | $-14.8M | $-2.9M | ||
| Q4 24 | $-6.6M | $-22.4M | ||
| Q3 24 | $-16.2M | $-3.1M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | $15.6M | $-567.0K |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | -17.7% | ||
| Q3 25 | -9.9% | -13.6% | ||
| Q2 25 | — | -5.9% | ||
| Q1 25 | -25.7% | -4.4% | ||
| Q4 24 | -6.0% | -33.1% | ||
| Q3 24 | -46.9% | -6.7% | ||
| Q2 24 | — | -5.5% | ||
| Q1 24 | -2.5% | -2.2% |
| Q4 25 | — | -24.7% | ||
| Q3 25 | -32.1% | -15.8% | ||
| Q2 25 | — | -5.0% | ||
| Q1 25 | -42.0% | -4.6% | ||
| Q4 24 | -20.2% | -33.1% | ||
| Q3 24 | -65.7% | -4.3% | ||
| Q2 24 | — | -3.6% | ||
| Q1 24 | 43.8% | -0.7% |
| Q4 25 | — | $-0.12 | ||
| Q3 25 | $-0.29 | $-0.07 | ||
| Q2 25 | — | $-0.02 | ||
| Q1 25 | $-0.47 | $-0.02 | ||
| Q4 24 | $-0.25 | $-0.18 | ||
| Q3 24 | $-0.53 | $-0.02 | ||
| Q2 24 | — | $-0.02 | ||
| Q1 24 | $0.42 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $104.9M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $227.9M |
| Total Assets | $235.2M | $290.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $104.9M | ||
| Q3 25 | $18.9M | $106.3M | ||
| Q2 25 | — | $112.9M | ||
| Q1 25 | $5.4M | $107.1M | ||
| Q4 24 | $9.5M | $109.2M | ||
| Q3 24 | — | $105.2M | ||
| Q2 24 | — | $106.3M | ||
| Q1 24 | — | $127.0M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $227.9M | ||
| Q3 25 | $-10.5M | $238.9M | ||
| Q2 25 | — | $245.3M | ||
| Q1 25 | $2.2M | $244.1M | ||
| Q4 24 | $15.4M | $244.7M | ||
| Q3 24 | $-3.9M | $265.2M | ||
| Q2 24 | — | $263.6M | ||
| Q1 24 | $17.7M | $288.4M |
| Q4 25 | — | $290.6M | ||
| Q3 25 | $235.2M | $299.2M | ||
| Q2 25 | — | $316.2M | ||
| Q1 25 | $237.7M | $313.8M | ||
| Q4 24 | $255.4M | $323.0M | ||
| Q3 24 | $246.8M | $330.6M | ||
| Q2 24 | — | $333.4M | ||
| Q1 24 | $246.2M | $357.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $3.7M |
| Free Cash FlowOCF − Capex | $25.0K | $3.6M |
| FCF MarginFCF / Revenue | 0.1% | 6.5% |
| Capex IntensityCapex / Revenue | 5.6% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $25.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.7M | ||
| Q3 25 | $1.8M | $5.7M | ||
| Q2 25 | — | $13.6M | ||
| Q1 25 | $1.2M | $3.3M | ||
| Q4 24 | $-6.1M | $11.6M | ||
| Q3 24 | $-613.0K | $14.6M | ||
| Q2 24 | — | $14.5M | ||
| Q1 24 | $-1.4M | $5.0M |
| Q4 25 | — | $3.6M | ||
| Q3 25 | $25.0K | $5.4M | ||
| Q2 25 | — | $13.2M | ||
| Q1 25 | $-4.3M | $3.2M | ||
| Q4 24 | $-8.6M | $11.5M | ||
| Q3 24 | $-4.0M | $13.9M | ||
| Q2 24 | — | $12.8M | ||
| Q1 24 | $-7.8M | $3.6M |
| Q4 25 | — | 6.5% | ||
| Q3 25 | 0.1% | 9.3% | ||
| Q2 25 | — | 22.3% | ||
| Q1 25 | -12.1% | 5.1% | ||
| Q4 24 | -26.3% | 16.9% | ||
| Q3 24 | -16.3% | 19.6% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | -21.8% | 4.6% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | 5.6% | 0.5% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | 15.5% | 0.2% | ||
| Q4 24 | 7.5% | 0.2% | ||
| Q3 24 | 13.9% | 0.9% | ||
| Q2 24 | — | 2.4% | ||
| Q1 24 | 17.8% | 1.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
MYPS
Segment breakdown not available.
